Factors associated with hepatitis B virus infection in indigenous communities of Colombia
Abstract
Introduction. Colombia is home to 2 million indigenous people who live in conditions of poverty and with health deficiencies, making them vulnerable to contracting hepatitis B (HBV). Amazonas has a high virus prevalence, and there are barriers to accessing vaccination; thus, part of the population is susceptible to infection.
Objective. To identify factors associated with HBV in Colombian indigenous people.
Materials and Methods. A case-control study of people over 18 years from four departments of Colombia. Cases were identified through the national hepatitis B notification registry (2015-2022). Controls were selected and matched to cases (2:1) by age, sex, ethnicity, and department. Sociodemographic characteristics, factors associated with contact with body fluids, cultural practices, and vaccination history were identified by means of a survey. The ethics committee of the Universidad de Antioquia approved the project.
Results. Seventy five cases and 150 controls from 13 ethnic groups were surveyed. Amazonas contributed 49% of participants, 83% were women, and the median age of
cases was 30 years (IQ range: 27-37). The associated factors were a family history of hepatitis B [adjusted OR: 2.61 (95% CI: 1.09-6.27)] and, in women, the number of
pregnancies [adjusted OR: 1.61 (95% CI 1.02- 2.54)]. The vaccination history showed a protective effect, but the association was not significant.
Conclusion. Aspects associated with family life and unprotected sexual relations seem to be responsible for the potential transmission of the virus. It was not possible to identify associated cultural practices. Innovative and differential strategies are required for indigenous people to achieve a reduction of HBV.
Downloads
References
Organización Panamericana de la Salud. Prestación de servicios de salud en zonas con pueblos indígenas. Quito: OPS; 2019.
Ministerio de Cultura. Caracterizaciones de los pueblos indígenas de Colombia. 2015. Fecha de consulta: 26 de septiembre de 2022. Disponible en: https://www.mincultura.gov.co/prensa/noticias/Documents/Poblaciones/PUEBLO%20WAYÚU.pdf
Organización Mundial de la Salud. Subsanar las desigualdades en una generación - ¿Cómo? 2017. Fecha de consulta: 22 de noviembre de 2019. Disponible en: https://www.who.int/social_determinants/thecommission/finalreport/closethgap_how/es/
Castro-Arroyave DM, Martínez-Gallego JA, Montoya-Guzmán M, Silva G, Rojas Arbeláez CA. Hepatitis B en indígenas de América Latina: una revisión de la literatura. Rev Panam Salud Pública. 2022;46:e22. https://doi.org/10.26633/RPSP.2022.22
De La Hoz F, Martínez Durán M, Iglesias Gamarra A, Velandia M, Rojas M. Factores de riesgo en la transmisión de la hepatitis B en la Amazonía colombiana. Biomédica. 1992;12:5. https://doi.org/10.7705/biomedica.v12i1.2014
Instituto Nacional de Salud. Boletín Epidemiológico semana 27 de 2019. Bogotá, D.C.: INS; 2019. p. 1-5. Fecha de consulta: 25 de noviembre de 2019. Disponible en: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2019%20Bolet%C3%ADn%20epidemiológico%20semana%2028.pdf
De La Hoz F, Pérez L, de Neira M, Hall AJ. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: Factors influencing hepatitis B virus infection and effectiveness. Int J Infect Dis. 2008;12:183-9. https://doi.org/10.1016/j.ijid.2007.06.010
Porras A, De La Hoz F. Impacto de la vacunación contra hepatitis B en el Amazonas colombiano 18 años después de su introducción. Rev Fac Nac Salud Pública. 2012;30(Suppl.1):32-5.
Ministerio de Salud. Colombia. Vacuna contra la hepatitis B. Fecha de consulta: 8 de mayo de 2020. Disponible en: https://www.minsalud.gov.co/Documentos%20y%20Publicaciones/Vacuna%20contra%20Hepatitis%20B.pdf
Ríos-Hincapié CY, Murad-Rivera R, Tohme RA, Ropero AM, Gómez B, Librado D, et al. Progress towards the elimination of hepatitis B in children in Colombia: A novel two-phase study approach. J Viral Hepat. 2022;29:737-47. https://doi.org/10.1111/jvh.13719
Cabezas C, Suárez M, Romero G, Carrillo C, García M, Reátegui J, et al. Hiperendemicidad de hepatitis viral Beta y Delta en pueblos indígenas de la Amazonía Peruana. Rev Peru Med Exp Salud Pública. 2006;23:114-22.
Monsalve-Castillo F, Echevarría J, Atencio R, Suárez A, Estévez J, Costa-León L, et al . Alta prevalencia de la infección por el virus de hepatitis B en la comunidad indígena Japreira, Estado Zulia, Venezuela. Cad Saúde Pública. 2008;24:1183-6. https://doi.org/10.1590/S0102-311X2008000500028
Cardona-Chorro N, Duarte M, Poblete F, Del Valle K, Mayila D, Pacheco M. Prevalencia y riesgo de infección por hepatitis B en población indígena de la Cuenca del Cataniapo. Estado Amazonas, Venezuela. Boletín Venezolano de Infectología. 2015;26:131-5.
Organización Mundial de la Salud. Eliminate hepatitis. 2017. Fecha de consulta: 13 de marzo de 2020. Disponible en: https://www.who.int/news-room/detail/27-07-2017-eliminatehepatitis-who
Organización Mundial de la Salud. Hepatitis B. 2022. Fecha de consulta: 29 de agosto de 2022. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/hepatitis-b
Di Filippo-Villa D, Cortés-Mancera F, Payares E, Montes N, De la Hoz F, Arbelaez P, et al. Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia. Virol J. 2015;12:172. https://doi:10.1186/s12985-015-0402-5
Silva-Miranda BW. Infecção pelos vírus das hepatitis B E D entre grupos indígenas da Amazônia Brasileira: aspectos epidemiológicos. Rev Soc Bras Med Trop. 2004;37(Suppl.2):9-13. https://doi.org/10.1590/S0037-86822004000700002
Craxi A, Tiné F, Vinci M, Almasio P, Camma C, Garofalo G, et al. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: A regression analysis of indicators of risk. Am J Epidemiol. 1991;134:641-50. https://doi.org/10.1093/oxfordjournals.aje.a116136
Cabezas C, Anaya E, Bartalesi F, Sánchez J. Transmisión horizontal de hepatitis viral B en población desplazada de un área hiperendémica a sus contactos en un área de baja endemicidad del Perú. Rev Gastroenterol Perú. 1997;17:128-34.
Cabezas C, Balbuena-Torres J, Crispín LJ, Landa Huaman C, Ríos-Rojas J, Sucari-Idrogo A, et al. Búsqueda de infección por hepatitis B en familiares de portadores crónicos de la provincia de Huanta, Ayacucho-Perú. Rev Peru Med Exp Salud. 2018;35:647-51. https://doi.org/10.17843/rpmesp.2018.354.3833
Melo LB, Fonseca JC, Souza RB, Braga WS, Toledo LM. Prevalence of hepatitis B virus markers within household contacts in the State of Amazonas. Rev Soc Bras Med Trop. 2003;36:565-70. https://doi.org/10.1590/s0037-86822003000500004
Moreno D, Alegre F, García-González N. Virología, epidemiología y mecanismos de transmisión del VHB. An Sist Sanit. 2004;27(Suppl.2):7-16.
Castro-Tigua JJ, Guerrero-Tóala MM, Giler-Zambrano XA. Hepatitis infecciosa en niños y adolescentes en América Latina. Revista Higía de la Salud. 2022;7. https://doi.org/10.37117/higia.v7i2.728
Umer A, Teklemariam Z, Ayele F, Mengesha MM. Prevalence of hepatitis B infection and its associated factors among pregnant mothers attending antenatal care at public hospitals at Hararghe, Eastern Ethiopia. Front Glob Womens Health. 2023;4:1056488. https://doi.org/10.3389/fgwh.2023.1056488
Salinas D. Prevalencia de hepatitis B y factores de riesgo en su transmisión, municipio de Huacareta abril a noviembre 2009. Rev Cien Tec In. 2009;18.
Bancha B, Kinfe AA, Chanko KP, Workie SB, Tadese T. Prevalence of hepatitis B viruses and associated factors among pregnant women attending antenatal clinics in public hospitals of Wolaita Zone, South Ethiopia. PLoS ONE. 2020;15:e0232653. https://doi.org/10.1371/journal.pone.0232653
Joshi SS, Coffin CS. Hepatitis B and pregnancy: Virologic and immunologic characteristics. Hepatol Commun. 2020;4:157-71. https://doi.org/10.1002/hep4.1460
Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370-98. https://doi.org/10.1016/j.jhep.2017.03.021
Jaramillo CM, Navas MC. Variantes de escape del virus de la hepatitis B. Rev Chil Infectol. 2015;32:190-7. https://doi.org/10.4067/S0716-10182015000300008
Vildozola H. Vacunación contra hepatitis B: veinte años después. Rev Gastroenterol Peru. 2007;27:57-66.
Ministerio de Salud. Norma técnica para la detección temprana de las alteraciones del embarazo. Fecha de consulta: 30 de agosto de 2022. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/norma-tecnica-para-la-detecciontemprana-embarazo.pdf
Some similar items:
- Mauricio Beltrán, María Cristina Navas, María Patricia Arbeláez, Jorge Donado, Sergio Jaramillo, Fernando De la Hoz, Cecilia Estrada, Lucía del Pilar Cortés, Amalia de Maldonado, Gloria Rey, Seroprevalence of hepatitis B virus and human immunodeficiency virus infection in a population of multiply-transfused patients in Colombia , Biomedica: Vol. 29 No. 2 (2009)
- Ligia Inés Moncada, Sandra Milena Rios, Julián Alfredo Fernández, Fabio Rivas, María Luz Sáenz, Pediculosis prevalence and associated risk factors in a nursery school, Bogotá, Colombia , Biomedica: Vol. 28 No. 2 (2008)
- Alicia Norma Alayón, Saudith Ariza, Karen Baena, Lina Lambis, Lina Martínez, Lourdes Benítez, Active search and assessment of cardiovascular risk factors in young adults, Cartagena de Indias, 2007 , Biomedica: Vol. 30 No. 2 (2010)
- María del Pilar Chaves, Julián Alfredo Fernández, Isabel Ospina, Myriam Consuelo López, Ligia Moncada, Patricia Reyes, Giardia duodenalis prevalence and associated risk factors in preschool and school-age children of rural Colombia , Biomedica: Vol. 27 No. 3 (2007)
- Elpidia Poveda, Alexandra Cuartas, Saralicia Guarín, Yibby Forero, Elsa Villarreal, Iron and vitamin A micronutrient status, risk factors for their deficiencies and anthropometric assessment in preschool child from Funza municipality, Colombia , Biomedica: Vol. 27 No. 1 (2007)
- Richard Hoyos, Lisandro Pacheco, Luz Adriana Agudelo, German Zafra, Pedro Blanco, Omar Triana, Seroprevalence of Chagas disease and associated risk factors in a population of Morroa, Sucre , Biomedica: Vol. 27 No. 1esp (2007): Enfermedad de Chagas
- Hollman Miller, Germán Gallego, Gerzaín Rodríguez, Clinical evidence of trachoma in Colombian Amerindians of the Vaupés Province , Biomedica: Vol. 30 No. 3 (2010)
- Constanza Pardo, Marion Piñeros, Teenage tobacco consumption in five Colombian cities , Biomedica: Vol. 30 No. 4 (2010)
- Gladys Acuña-González, Carlo E. Medina-Solís, Gerardo Maupomé, Mauricio Escoffie-Ramírez, Jesús Hernández-Romano, María de L. Márquez-Corona, Arturo J. Islas-Márquez, Juan J. Villalobos-Rodelo, Family history and socioeconomic risk factors for non-syndromic cleft lip and palate: A matched case-control study in a less developed country , Biomedica: Vol. 31 No. 3 (2011)
- Mauricio Beltrán, Maritza Berrío-Pérez, María Isabel Bermúdez, Gloria Rey-Benito, Bernardo Camacho, Patricia Forero, Gloria Cristina Molina, Orlando Fals, Isabel Pisciotti, Yulieth Oliveros, Armando Cortés, Fernando De La Hoz, Absence of occult hepatitis B in Colombian blood donors , Biomedica: Vol. 31 No. 4 (2011)
Copyright (c) 2024 Biomedica
This work is licensed under a Creative Commons Attribution 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
